AI assistant
Sending…
Alligator Bioscience — Major Shareholding Notification 2023
Jul 6, 2023
3138_iss_2023-07-06_36ff84c3-686b-4d75-b5e9-a259b0ee8bd6.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Alligator Bioscience AB
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument | |
|---|---|
| Instrument | Aktier |
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 05/07/2023 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 30,985,134 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 30,985,134 |
| Percentage | |
| Directly held shares | 4.96139 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.96819 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.96819 % | 30,985,134 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
0.02317 % | 144,485 |
| Total | 4.99136 % | 31,129,619 |
Group total holdings
Voting rights 31,129,619 Percentage of voting rights 4.99136
Notes (other relevant informations according to law)
Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.
Published
06/07/2023 10:07
Contact
Name Marie Andersson
Email [email protected]
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Alligator Bioscience
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Quarterly Report
2026
May 5
Quarterly Report
2026
May 5
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Board/Management Information
2026
Mar 27
Board/Management Information
2026
Mar 27